Factors predicting early recurrence in patients with unresectable stage III non-small cell lung cancer on durvalumab consolidation after chemoradiotherapy.

Transl Lung Cancer Res · 2025 · PMC12082245 · PMID 40386716

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

In such patients, a favorable trend was apparent, but statistical significance was not reached (HR, 0.80; 95% CI: 0.53–1.20).

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.